Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long before symptoms appear, a new study indicates.

Carmen A. Guzman, 75, was reported missing on Sept. 19 when he was last seen with family at Hardee’s restaurant, 913 E. Main ...

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

The Ministry of Health, Labour and Welfare Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks ...

We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...

Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...